Patterns of Sensitivity Exhibited By Venetoclax-Inclusive Drug Combinations in Acute Myeloid Leukemia

被引：1
作者：
Kurtz, Stephen E. [1 ,2 ]
Eide, Christopher A. [1 ]
Kaempf, Andy [3 ]
Long, Nicola [1 ]
Agarwal, Anupriya [1 ]
Tognon, Cristina E. [1 ]
Mori, Motomi [3 ]
Druker, Brian J. [1 ]
Tyner, Jeffrey W. [4 ]
机构：
[1] Oregon Hlth & Sci Univ, Knight Canc Inst, Div Hematol & Med Oncol, Mail Code KR HEM, Portland, OR 97201 USA
[2] Oregon Hlth & Sci Univ, Knight Canc Inst, Mail Code KR HEM, Portland, OR 97201 USA
[3] Oregon Hlth & Sci Univ, Knight Canc Inst, Biostat Shared Resource, Portland, OR 97201 USA
[4] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97201 USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-126020
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
878
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Synergistic drug combinations promote the development of resistance in acute myeloid leukemia
    Mason-Osann, Emily
    Pomeroy, Amy E.
    Palmer, Adam C.
    Mettetal, Jerome T.
    CANCER RESEARCH, 2023, 83 (07)
  • [32] Acid ceramidase inhibition enhances venetoclax sensitivity in preclinical models of acute myeloid leukemia
    Ung, Johnson
    Tan, Su-Fern
    Shaw, Jeremy J.
    Fox, Todd E.
    Taori, Maansi
    Claxton, David F.
    Fisher-Wellman, Kelsey H.
    Cabot, Myles C.
    Feith, David J.
    Loughran, Thomas P.
    CANCER RESEARCH, 2024, 84 (06)
  • [33] Effective orally available drug combination of OR2100 and venetoclax in acute myeloid leukemia
    Ureshino, Hiroshi
    Watanabe, Tatsuro
    Kimura, Shinya
    CANCER SCIENCE, 2023, 114 : 44 - 44
  • [34] Treatment of Acute Myeloid Leukemia With Venetoclax-Based Combinations in Argentina: A Real-World Study
    Rivero Equiza, Tomas
    Cazap, Nicolas
    Garcia Altuve, Juan Ignacio
    Fornillo, Florencia
    Maymo, Daniela
    Riera, Leandro
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S323 - S324
  • [35] Venetoclax-based therapies for acute myeloid leukemia
    Guerra, Veronica A.
    DiNardo, Courtney
    Konopleva, Marina
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2019, 32 (02) : 145 - 153
  • [36] Venetoclax for every patient diagnosed with acute myeloid leukemia?
    Cailly, Laura
    Gallego-Hernanz, Maria-Pilar
    Torregrosa-Diaz, Jose-Miguel
    HEMATOLOGIE, 2022, 28 (01): : 6 - 8
  • [37] Biomarkers of Response to Venetoclax Therapy in Acute Myeloid Leukemia
    Rodriguez-Medina, Carlos
    Stuckey, Ruth
    Bilbao-Sieyro, Cristina
    Gomez-Casares, Maria Teresa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (03)
  • [38] Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia
    DiNardo, C. D.
    Jonas, B. A.
    Pullarkat, V.
    Thirman, M. J.
    Garcia, J. S.
    Wei, A. H.
    Konopleva, M.
    Doehner, H.
    Letai, A.
    Fenaux, P.
    Koller, E.
    Havelange, V.
    Leber, B.
    Esteve, J.
    Wang, J.
    Pejsa, V.
    Hajek, R.
    Porkka, K.
    Illes, A.
    Lavie, D.
    Lemoli, R. M.
    Yamamoto, K.
    Yoon, S. -S.
    Jang, J. -H.
    Yeh, S. -P.
    Turgut, M.
    Hong, W. -J.
    Zhou, Y.
    Potluri, J.
    Pratz, K. W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (07) : 617 - 629
  • [39] Abbreviated venetoclax with decitabine or azacitidine in acute myeloid leukemia
    Bouligny, Ian M.
    Murray, Graeme
    Ho, Thuy
    Doyel, Michael
    Patel, Tilak
    Boron, Josh
    Tran, Valerie
    Gor, Juhi
    Hang, Yiwei
    Alnimer, Yanal
    Zacholski, Kyle
    Venn, Chad
    Wages, Nolan A.
    Grant, Steven
    Maher, Keri R.
    LEUKEMIA RESEARCH, 2023, 134
  • [40] Venetoclax in acute myeloid leukemia - current and future directions
    Lachowiez, Curtis
    DiNardo, Courtney D.
    Konopleva, Marina
    LEUKEMIA & LYMPHOMA, 2020, 61 (06) : 1313 - 1322
12345